(1->4)-beta-D-glucan multiple interactions ISO RGD:10572 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FCER1G mRNA CTD PMID:36331819 1,1-dichloroethene increases expression ISO RGD:10572 6480464 vinylidene chloride results in increased expression of FCER1G mRNA CTD PMID:26682919 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile multiple interactions ISO RGD:736226 6480464 Citalopram inhibits the reaction [convulxin promotes the reaction [FCER1G protein binds to SYK protein]] CTD PMID:30592962 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FCER1G mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:10572 6480464 Ethinyl Estradiol results in increased expression of FCER1G mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:10572 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FCER1G mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:10572 6480464 Estradiol results in increased expression of FCER1G mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCER1G mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCER1G mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10572 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FCER1G mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FCER1G mRNA CTD PMID:17942748 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FCER1G mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10572 6480464 Tetrachlorodibenzodioxin affects the expression of FCER1G mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10572 6480464 Tetrachlorodibenzodioxin results in increased expression of FCER1G mRNA CTD PMID:21041162 2,5-hexanedione increases expression EXP 6480464 2, 5-hexanedione results in increased expression of FCER1G mRNA CTD PMID:22952946 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of FCER1G mRNA CTD PMID:28300664 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of FCER1G mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression ISO RGD:10572 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of FCER1G mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:10572 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FCER1G mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FCER1G mRNA CTD PMID:36041667 5-aza-2'-deoxycytidine increases expression ISO RGD:736226 6480464 Decitabine results in increased expression of FCER1G mRNA CTD PMID:19194470 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FCER1G mRNA CTD PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of FCER1G mRNA CTD PMID:31881176 acetylsalicylic acid decreases expression ISO RGD:736226 6480464 Aspirin results in decreased expression of FCER1G mRNA CTD PMID:15928584 acetylsalicylic acid affects response to substance ISO RGD:736226 6480464 FCER1G SNP affects the susceptibility to Aspirin CTD PMID:18534082 , PMID:18595682 aldehydo-D-glucose decreases expression ISO RGD:10572 6480464 Glucose results in decreased expression of FCER1G mRNA CTD PMID:31525975 all-trans-retinoic acid increases expression ISO RGD:736226 6480464 Tretinoin results in increased expression of FCER1G mRNA CTD PMID:15498508 more ... amitrole increases expression EXP 6480464 Amitrole results in increased expression of FCER1G mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FCER1G mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of FCER1G mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:736226 6480464 Antirheumatic Agents results in decreased expression of FCER1G mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:736226 6480464 aristolochic acid I results in increased expression of FCER1G mRNA CTD PMID:33212167 arsenous acid multiple interactions ISO RGD:736226 6480464 [Arsenic Trioxide co-treated with nilotinib] affects the expression of FCER1G mRNA CTD PMID:28786057 beclomethasone decreases expression EXP 6480464 Beclomethasone results in decreased expression of FCER1G protein CTD PMID:1834581 benzo[a]pyrene decreases expression ISO RGD:10572 6480464 Benzo(a)pyrene results in decreased expression of FCER1G mRNA CTD PMID:21569818 benzo[a]pyrene increases methylation ISO RGD:10572 6480464 Benzo(a)pyrene results in increased methylation of FCER1G promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10572 6480464 Benzo(a)pyrene results in increased expression of FCER1G mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736226 6480464 Diethylhexyl Phthalate results in increased expression of FCER1G mRNA CTD PMID:28412506 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FCER1G mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FCER1G mRNA CTD PMID:36041667 bisphenol A multiple interactions ISO RGD:736226 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of FCER1G gene CTD PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FCER1G gene CTD PMID:28505145 bisphenol F increases expression ISO RGD:10572 6480464 bisphenol F results in increased expression of FCER1G mRNA CTD PMID:30951980 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FCER1G mRNA CTD PMID:36041667 calcitriol decreases expression ISO RGD:736226 6480464 Calcitriol results in decreased expression of FCER1G mRNA CTD PMID:26485663 carbon nanotube affects expression ISO RGD:10572 6480464 Nanotubes, Carbon affects the expression of FCER1G mRNA CTD PMID:23845593 carbon nanotube increases expression ISO RGD:10572 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone increases expression ISO RGD:10572 6480464 Chlordecone results in increased expression of FCER1G mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:10572 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of FCER1G mRNA more ... CTD PMID:20938992 , PMID:29246445 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of FCER1G mRNA CTD PMID:22023808 citalopram multiple interactions ISO RGD:736226 6480464 Citalopram inhibits the reaction [convulxin promotes the reaction [FCER1G protein binds to SYK protein]] CTD PMID:30592962 copper atom decreases expression EXP 6480464 Copper results in decreased expression of FCER1G mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of FCER1G mRNA CTD PMID:30556269 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of FCER1G mRNA CTD PMID:27523638 cyclophosphamide increases expression ISO RGD:10572 6480464 Cyclophosphamide results in increased expression of FCER1G mRNA CTD PMID:21041162 D-glucose decreases expression ISO RGD:10572 6480464 Glucose results in decreased expression of FCER1G mRNA CTD PMID:31525975 dexamethasone increases expression ISO RGD:10572 6480464 Dexamethasone results in increased expression of FCER1G mRNA CTD PMID:21041162 dextran sulfate multiple interactions ISO RGD:10572 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCER1G mRNA CTD PMID:29950665 diarsenic trioxide multiple interactions ISO RGD:736226 6480464 [Arsenic Trioxide co-treated with nilotinib] affects the expression of FCER1G mRNA CTD PMID:28786057 diclofenac increases expression ISO RGD:10572 6480464 Diclofenac results in increased expression of FCER1G mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO RGD:10572 6480464 Diethylstilbestrol results in increased expression of FCER1G mRNA CTD PMID:21041162 diquat decreases expression ISO RGD:10572 6480464 Diquat results in decreased expression of FCER1G mRNA, Diquat results in decreased expression of FCER1G protein CTD PMID:36851058 diuron decreases expression EXP 6480464 Diuron results in decreased expression of FCER1G mRNA CTD PMID:25152437 fenbuconazole increases expression ISO RGD:736226 6480464 fenbuconazole results in increased expression of FCER1G mRNA CTD PMID:15942997 folic acid multiple interactions ISO RGD:10572 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FCER1G mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:10572 6480464 Folic Acid results in decreased expression of FCER1G mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:736226 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of FCER1G gene CTD PMID:31601247 ginkgolide B decreases expression EXP 6480464 ginkgolide B results in decreased expression of FCER1G protein CTD PMID:1834581 glucose decreases expression ISO RGD:10572 6480464 Glucose results in decreased expression of FCER1G mRNA CTD PMID:31525975 ketotifen decreases expression EXP 6480464 Ketotifen results in decreased expression of FCER1G protein CTD PMID:1834581 L-methionine multiple interactions ISO RGD:10572 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FCER1G mRNA CTD PMID:20938992 lipopolysaccharide increases expression ISO RGD:10572 6480464 Lipopolysaccharides results in increased expression of FCER1G mRNA CTD PMID:27339419 lipopolysaccharide multiple interactions ISO RGD:736226 6480464 [Acetaminophen co-treated with Lipopolysaccharides] affects the expression of FCER1G mRNA CTD PMID:31059760 lipopolysaccharide increases expression ISO RGD:736226 6480464 Lipopolysaccharides results in increased expression of FCER1G mRNA CTD PMID:31059760 mercury atom affects response to substance ISO RGD:10572 6480464 FCER1G protein affects the susceptibility to Mercury CTD PMID:20976163 mercury(0) affects response to substance ISO RGD:10572 6480464 FCER1G protein affects the susceptibility to Mercury CTD PMID:20976163 methimazole increases expression EXP 6480464 Methimazole results in increased expression of FCER1G mRNA CTD PMID:30047161 methotrexate decreases expression ISO RGD:736226 6480464 Methotrexate results in decreased expression of FCER1G mRNA CTD PMID:17400583 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of FCER1G mRNA CTD PMID:31378766 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FCER1G mRNA CTD PMID:28943392 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of FCER1G mRNA CTD PMID:25380136 nickel atom increases expression ISO RGD:736226 6480464 Nickel results in increased expression of FCER1G mRNA CTD PMID:24768652 , PMID:25583101 nilotinib multiple interactions ISO RGD:736226 6480464 [Arsenic Trioxide co-treated with nilotinib] affects the expression of FCER1G mRNA CTD PMID:28786057 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of FCER1G mRNA CTD PMID:22124623 ozone increases expression EXP 6480464 Ozone results in increased expression of FCER1G mRNA CTD PMID:16716893 ozone multiple interactions ISO RGD:10572 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FCER1G mRNA CTD PMID:34911549 ozone multiple interactions ISO RGD:736226 6480464 [Ozone results in increased abundance of Soot metabolite] which results in decreased expression of FCER1G mRNA CTD PMID:28410501 paracetamol affects expression ISO RGD:10572 6480464 Acetaminophen affects the expression of FCER1G mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:736226 6480464 Acetaminophen results in decreased expression of FCER1G mRNA CTD PMID:31059760 paracetamol multiple interactions ISO RGD:736226 6480464 [Acetaminophen co-treated with Lipopolysaccharides] affects the expression of FCER1G mRNA CTD PMID:31059760 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10572 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FCER1G mRNA CTD PMID:36331819 probucol multiple interactions ISO RGD:10572 6480464 Probucol promotes the reaction [APOE gene mutant form results in increased expression of FCER1G mRNA] CTD PMID:19394937 quercetin increases expression ISO RGD:736226 6480464 Quercetin results in increased expression of FCER1G mRNA CTD PMID:21632981 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of FCER1G mRNA CTD PMID:25905778 serpentine asbestos decreases expression ISO RGD:736226 6480464 Asbestos, Serpentine results in decreased expression of FCER1G mRNA CTD PMID:24160326 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of FCER1G mRNA CTD PMID:32721576 sodium arsenite multiple interactions ISO RGD:736226 6480464 sodium arsenite results in decreased expression of and affects the splicing of FCER1G mRNA CTD PMID:25879800 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of FCER1G mRNA CTD PMID:22561333 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of FCER1G mRNA CTD PMID:25905778 tamibarotene increases expression ISO RGD:736226 6480464 tamibarotene results in increased expression of FCER1G mRNA CTD PMID:15498508 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCER1G mRNA CTD PMID:32741896 testosterone enanthate affects expression ISO RGD:736226 6480464 testosterone enanthate affects the expression of FCER1G mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:10572 6480464 Carbon Tetrachloride results in increased expression of FCER1G mRNA CTD PMID:27339419 more ... thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FCER1G mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FCER1G mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:10572 6480464 titanium dioxide results in increased expression of FCER1G mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:10572 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCER1G mRNA CTD PMID:29950665 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of FCER1G mRNA CTD PMID:30589522 troglitazone increases expression ISO RGD:10572 6480464 troglitazone results in increased expression of FCER1G mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:10572 6480464 Tungsten results in decreased expression of FCER1G mRNA CTD PMID:30912803 valproic acid decreases expression ISO RGD:736226 6480464 Valproic Acid results in decreased expression of FCER1G mRNA CTD PMID:29154799 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FCER1G mRNA CTD PMID:23034163